Monitoring recombinant factor VIIa treatment: efficacy depends on high levels of fibrinogen in a model of severe dilutional coagulopathy.
D000328:Adult; D001780:Blood Coagulation Tests; D015942:Factor VIIa / Q000627:therapeutic use*; D005340:Fibrinogen / Q000627:therapeutic use*; D006438:Hemodilution / Q000009:adverse effects*; D006801:Humans; D008297:Male; D019095:Point-of-Care Systems; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D005340:Fibrinogen; C103587:recombinant FVIIa; D015942:Factor VIIa